Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.

about

Trigger factors of cutaneous lupus erythematosus: a review of current literature.

P2860

Q38973692-1814AF8C-1274-4742-A5AE-0BE9BA5CA0FF

P2860

Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.

Item

http://www.wikidata.org/entity/Q46068495

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@en

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@nl

type

Item

label

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@en

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@nl

prefLabel

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@en

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@nl

P1476

Adalimumab-Induced Cutaneous L ...... Juvenile Idiopathic Arthritis.

@en

P2093

Emily S West

http://www.w3.org/2001/XMLSchema#string

Heather A Brandling-Bennett

http://www.w3.org/2001/XMLSchema#string

Joe Rutledge

http://www.w3.org/2001/XMLSchema#string

Kabita Nanda

http://www.w3.org/2001/XMLSchema#string

Ope Ofodile

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.

Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Autoimmune diseases induced by biological agents: a double-edged sword?

TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.

Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections.

Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies.

P304

e140-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PDE.12576

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25845414

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab

juvenile rheumatoid arthritis

Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.

about

P2860

P2860

Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921